Details of the Drug

General Information of Drug (ID: DMFHGCC)

Drug Name
RG6315
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Phase 1 [1]
Cross-matching ID
TTD ID
D39NLO

References

1 Clinical pipeline report, company report or official report of Roche